ResearcherWuhan Union HospitalActive in the last 2 years

Long He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2814-6541; OpenAlex author ID A5102017345. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 2 papers

Papers 2

A matrix stiffness gene signature identifies SLC20A1 as a novel mechano-immunological checkpoint enabling synergistic immunotherapy in pancreatic ductal adenoc… Co-author DOI 10.1007/s00262-025-04195-w ↗
Pancreatic cancer with liver metastasis benefits from chemoradiotherapy compared to chemotherapy alone: a retrospective cohort study from the Surveillance, Epi… Co-author DOI 10.21037/tcr-2025-464 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tao Yin · 2 shared papers, 2025 · strength 0.69
- Paper Pancreatic cancer with liver metastasis benefits from chemoradiotherapy compared to chemotherapy alone: a retrospective… DOI 10.21037/tcr-2025-464 ↗
- Paper A matrix stiffness gene signature identifies SLC20A1 as a novel mechano-immunological checkpoint enabling synergistic i… DOI 10.1007/s00262-025-04195-w ↗
Chuanbing Zhao · 1 shared paper, 2025 · strength 0.33
- Paper A matrix stiffness gene signature identifies SLC20A1 as a novel mechano-immunological checkpoint enabling synergistic i… DOI 10.1007/s00262-025-04195-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.